Complex Regional Pain Syndrome (CRPS)

**Complex Regional Pain Syndrome (CRPS)** — formerly known as Reflex Sympathetic Dystrophy (RSD) — is a chronic pain condition characterized by **pain that is disproportionate** to the inciting injury, accompanied by a constellation of sensory, vasomotor, sudomotor/edema, and motor/trophic changes in the affected limb. CRPS is classified into two types: - **CRPS Type I** (90% of cases) — No demonstrable nerve injury. Previously called Reflex Sympathetic Dystrophy (RSD). - **CRPS Type II** (10% of cases) — Confirmed nerve injury present. Previously called Causalgia. **The Classic Scenario:** A patient sustains a relatively minor injury — a wrist fracture, an ankle sprain, or minor surgery. Instead of healing normally over weeks, the pain **intensifies** and **persists** far beyond the expected healing time. The affected limb becomes swollen, changes color (red, blue, mottled), feels abnormally warm or cold, and becomes exquisitely sensitive to touch. Light contact from clothing or bedsheets causes severe pain (allodynia). Movement becomes increasingly difficult. **The Three Traditional Stages** (though progression is variable): 1. **Acute/Warm stage (months 1-3)** — Burning pain, swelling, warmth, redness, increased sweating, rapid hair/nail growth in the affected area 2. **Dystrophic/Cool stage (months 3-6)** — Pain intensifies, skin becomes cool and cyanotic (bluish), edema hardens, nail and hair growth changes, early joint stiffness and osteoporosis 3. **Atrophic stage (6+ months)** — Skin becomes thin and shiny, severe joint contractures, muscle atrophy, bone demineralization, pain may be intractable **Important**: Not all patients follow this staging, and early aggressive treatment can prevent progression. The key is **early recognition and treatment within the first 3-6 months**, which dramatically improves outcomes.

The pathophysiology of CRPS involves a "perfect storm" of multiple interacting mechanisms that transform normal post-injury healing into a self-perpetuating pain state: **1. Exaggerated Neurogenic Inflammation:** After injury, sensory nerve endings release inflammatory neuropeptides (substance P, CGRP, bradykinin). In CRPS, this neurogenic inflammation is **dramatically amplified and sustained** — the nerve endings continue releasing inflammatory mediators long after the initial injury has healed. This causes the persistent warmth, redness, swelling, and pain of early CRPS. **2. Central Sensitization:** Persistent pain signals from the periphery cause **neuroplastic changes** in the spinal cord and brain: - Spinal cord dorsal horn neurons become hyperexcitable — normal touch signals are amplified into pain signals (explaining allodynia) - The brain's pain processing centers (somatosensory cortex, anterior cingulate, insula) show altered activation patterns - The **body schema** is disrupted — fMRI studies show the affected limb's cortical representation shrinks and distorts, contributing to the feeling that the limb is "alien" or not part of the body **3. Sympathetic Nervous System Dysfunction:** The sympathetic nervous system — which normally controls blood flow, sweating, and temperature — becomes dysfunctional: - **Sympatho-afferent coupling** — sympathetic nerve fibers abnormally activate pain-sensing neurons, creating a vicious cycle where stress and emotional arousal increase pain - This explains why CRPS pain often worsens with emotional stress, cold exposure, or startle responses - Sympathetic dysfunction also causes the vasomotor (color, temperature) and sudomotor (sweating) changes **4. Autoimmune Mechanisms:** Emerging research has identified **autoantibodies** against beta-2 adrenergic receptors and muscarinic acetylcholine receptors in CRPS patients. These autoantibodies may directly cause sympathetic dysfunction and inflammation. This autoimmune component explains: - Why CRPS can spread to other limbs - Why some patients respond to immunomodulatory treatments (IVIG, plasma exchange) - The female predominance (autoimmune diseases are generally more common in women) **5. Peripheral Nerve Changes:** Even in CRPS Type I (no demonstrable nerve injury), studies show subtle changes in small nerve fibers — reduced epidermal nerve fiber density in the affected skin, suggesting small fiber neuropathy may contribute to sensory symptoms. **Why Early Treatment Matters:** In the first 3-6 months, CRPS is primarily driven by **peripheral inflammation** and early central sensitization — both of which are potentially reversible. After 6-12+ months, **structural neuroplastic changes** in the brain and spinal cord become established, making the condition much more resistant to treatment. This is why aggressive early intervention dramatically improves outcomes.

CRPS requires a **multidisciplinary approach** combining physical rehabilitation, pain management, psychological support, and sometimes interventional procedures. **Early treatment is critical** — outcomes are dramatically better when treatment begins within 3-6 months. **Tier 1: Physical/Occupational Therapy (The Foundation)** Physical therapy is the cornerstone of CRPS treatment — no other treatment works well without it: - **Graded motor imagery (GMI)** — A three-stage brain retraining program: 1. Left/right discrimination — identifying pictures of left vs right hands/feet (reactivates cortical representation) 2. Imagined movements — mentally rehearsing movements of the affected limb without actually moving 3. Mirror therapy — watching the unaffected limb move in a mirror (the brain "sees" the affected limb moving pain-free) - Evidence: 50-60% pain reduction in randomized controlled trials - **Graded exposure** — Very gentle, progressive movement and weight-bearing; gradually increasing as tolerance improves - **Desensitization** — Progressive exposure to different textures, temperatures, and pressures to reduce allodynia - **Edema management** — Elevation, gentle retrograde massage, compression garments - **Functional restoration** — Gradual return to normal hand/foot use and daily activities **Tier 2: Medications** - **Corticosteroids** (early CRPS, <3 months) — Prednisone 30-40mg/day tapering over 2-4 weeks. Most effective in acute, inflammatory CRPS. 70-80% improvement when used early. - **Gabapentin/Pregabalin** — For neuropathic pain component. Start low, titrate gradually. Moderate evidence. - **Low-dose naltrexone (LDN)** — 1-4.5mg at bedtime. Emerging evidence for neuroinflammatory conditions including CRPS. - **Bisphosphonates** (alendronate, pamidronate) — Reduce bone turnover and have anti-inflammatory effects. Good evidence for CRPS with bone demineralization. - **Topical treatments** — Capsaicin cream (desensitizes nerve fibers), lidocaine patches (local pain relief), DMSO cream (anti-inflammatory). - **Tricyclic antidepressants** (amitriptyline, nortriptyline) — For neuropathic pain and sleep improvement. **Tier 3: Interventional Procedures** - **Sympathetic nerve blocks** — Stellate ganglion block (upper extremity) or lumbar sympathetic block (lower extremity). 50-70% provide temporary relief; can be repeated. Also diagnostic — relief confirms sympathetically mediated pain. - **Spinal cord stimulation (SCS)** — An implanted device that delivers electrical impulses to the spinal cord, interrupting pain signals. 60-70% achieve >50% pain reduction. Best evidence-based interventional treatment for refractory CRPS. - **Intrathecal drug delivery** — Implanted pump delivering medication (baclofen for dystonia, opioids/ziconotide for pain) directly to the spinal cord. - **Ketamine infusion** — Subanesthetic IV ketamine (administered in specialized clinics). Strong NMDA receptor antagonist that can "reset" central sensitization. 50-70% report significant improvement. Effects may last weeks to months. - **Dorsal root ganglion (DRG) stimulation** — Newer, targeted neuromodulation with promising results for CRPS. **Tier 4: Psychological Support** - **Cognitive behavioral therapy (CBT)** — Addresses catastrophizing, fear-avoidance, and depression - **Acceptance and commitment therapy (ACT)** — For chronic CRPS - **Biofeedback** — Can help regulate autonomic nervous system function - Psychological support is NOT optional — it significantly impacts physical treatment outcomes **Prognosis:** - **Early treatment (<3 months)**: 70-80% achieve resolution or significant improvement - **Delayed treatment (6-12 months)**: 50-60% improve significantly - **Chronic CRPS (>1 year)**: 30-40% achieve full resolution; many can still achieve meaningful improvement - Children with CRPS generally have better outcomes than adults